We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+14.82%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$3.38B
AUM Growth
-$1.44B
Cap. Flow
-$1.68B
Cap. Flow %
-49.61%
Top 10 Hldgs %
44.12%
Holding
72
New
14
Increased
22
Reduced
16
Closed
4

Top Buys

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$82.8M
2
VST icon
Vistra
VST
+$60.1M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$53.7M
4
EXTR icon
Extreme Networks
EXTR
+$47M
5
FLR icon
Fluor
FLR
+$41.8M

Top Sells

Rank Stock Value
1
COLL icon
Collegium Pharmaceutical
COLL
+$32.3M
2
GDRX icon
GoodRx Holdings
GDRX
+$24.8M
3
KOP icon
Koppers
KOP
+$22.5M
4
ARDX icon
Ardelyx
ARDX
+$18.8M
5
COOP
Mr. Cooper
COOP
+$18.6M

Sector Composition

Rank Sector Weight
1 Healthcare 47.6%
2 Technology 8.46%
3 Financials 7.86%
4 Industrials 6.07%
5 Materials 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPER icon
26
Xperi
XPER
$323M
$48.8M 1.44%
4,043,744
+1,488,112
+58% +$16.4M
MREO
27
Mereo BioPharma
MREO
$47.6M
$44.7M 1.32%
13,552,997
– –
AIR icon
28
AAR Corp
AIR
$5.97B
$43.4M 1.28%
725,000
-170,904
-19% -$10.6M
KNSA icon
29
Kiniksa Pharmaceuticals
KNSA
$6.05B
$43.3M 1.28%
2,196,009
-711,492
-24% -$13.9M
PLYA
30
DELISTED
Playa Hotels & Resorts
PLYA
$40.3M 1.19%
4,155,840
-275,321
-6% -$2.43M
EXTR icon
31
Extreme Networks
EXTR
$3.21B
$39.8M 1.18%
+3,450,000
New +$47M
PLAY icon
32
Dave & Buster's
PLAY
$356M
$37.5M 1.11%
+598,503
New +$34.3M
ZYME icon
33
Zymeworks
ZYME
$1.77B
$36.6M 1.08%
3,475,384
– –
ATMU icon
34
Atmus Filtration Technologies
ATMU
$4.06B
$36.5M 1.08%
+1,132,056
New +$27.1M
ADPT icon
35
Adaptive Biotechnologies
ADPT
$3.96B
$33.7M 1%
10,500,000
+7,637,271
+267% +$29.6M
LBTYK icon
36
Liberty Global Class C
LBTYK
$3.45B
$33.4M 0.99%
1,893,293
+40,437
+2% +$778K
KOP icon
37
Koppers
KOP
$845M
$31.6M 0.93%
572,658
-434,683
-43% -$22.5M
TAC icon
38
TransAlta
TAC
$3.9B
$30.1M 0.89%
4,687,158
-458,472
-9% -$3.25M
PARR icon
39
Par Pacific Holdings
PARR
$3.87B
$28.6M 0.85%
772,384
-427,365
-36% -$15.7M
CNNE icon
40
Cannae Holdings
CNNE
$650M
$27M 0.8%
1,214,217
+851,256
+235% +$18M
SDGR icon
41
Schrodinger
SDGR
$1.39B
$27M 0.8%
+998,276
New +$27.9M
CAR icon
42
Avis
CAR
$4.95B
$26.3M 0.78%
+215,092
New +$29.7M
CHRS icon
43
Coherus Oncology
CHRS
$182M
$24.9M 0.73%
10,400,000
+10,004,793
+2,532% +$24.6M
RSKD icon
44
Riskified
RSKD
$781M
$22.6M 0.67%
4,173,636
– –
SWTX
45
DELISTED
SpringWorks Therapeutics
SWTX
$21M 0.62%
+426,768
New +$19.7M
FIP icon
46
FTAI Infrastructure
FIP
$552M
$20.1M 0.59%
3,193,530
– –
NUVL
47
DELISTED
Nuvalent
NUVL
$19.7M 0.58%
+261,874
New +$20.8M
TRVI icon
48
Trevi Therapeutics
TRVI
$2.51B
$19.2M 0.57%
5,564,123
-120,297
-2% -$268K
SCPH
49
DELISTED
scPharmaceuticals
SCPH
$17.7M 0.52%
3,525,000
+25,000
+0.7% +$140K
OVID icon
50
Ovid Therapeutics
OVID
$489M
$16.2M 0.48%
5,315,969
– –
1
2
3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2024 Portfolio in Review

As of Q1 2024, Rubric Capital Management (New York) held 72 positions worth $3.38B, down 30% from $4.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rubric Capital Management (New York) withdrew a net $1.68B in Q1 2024, closing 4 positions and reducing 16 holdings. Its most notable exit was Silk Road Medical, Inc. Common Stock, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Rubric Capital Management (New York) opened a new position in Vistra worth $84.6M.

  • Rubric Capital Management (New York)'s largest Q1 2024 buy was Vistra: 1,213,998 shares worth $84.6M.
  • Rubric Capital Management (New York) added most to QuidelOrtho in Q1 2024, an estimated $82.8M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2024 reduction was Collegium Pharmaceutical, cutting an estimated $32.3M.
  • Rubric Capital Management (New York) fully exited Silk Road Medical, Inc. Common Stock in Q1 2024, selling an estimated $17.5M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 44% of its $3.38B portfolio in Q1 2024.
  • Rubric Capital Management (New York) opened 14 new positions and closed 4 in Q1 2024.
  • Rubric Capital Management (New York)'s portfolio value fell 30% quarter-over-quarter to $3.38B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2024, filed 10 May 2024.